ornidazole has been researched along with fluconazole in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chothe, AS; Dudhe, PB; Gadhwe, S; Kathiravan, MK; Mukta, MS; Salake, AB; Watode, RP | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bavbek, S; Sözener, ZÇ; Yilmaz, İ | 1 |
1 review(s) available for ornidazole and fluconazole
| Article | Year |
|---|---|
The biology and chemistry of antifungal agents: a review.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Imidazoles; Mycoses | 2012 |
2 other study(ies) available for ornidazole and fluconazole
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Fixed drug eruption caused by ornidazole and fluconazole but not isoconazole, itraconazole, ketoconazole and metronidazole.
Topics: Adult; Antifungal Agents; Antiprotozoal Agents; Candidiasis, Vulvovaginal; Drug Eruptions; Female; Fluconazole; Humans; Ornidazole | 2013 |